Home/Filings/4/0000950170-24-076707
4//SEC Filing

Johnson David Michael 4

Accession 0000950170-24-076707

CIK 0001501796other

Filed

Jun 23, 8:00 PM ET

Accepted

Jun 24, 4:05 PM ET

Size

9.9 KB

Accession

0000950170-24-076707

Insider Transaction Report

Form 4
Period: 2024-06-20
Transactions
  • Award

    Common Stock

    2024-06-20+10,500146,167 total
  • Award

    Stock Option (Right to Buy)

    2024-06-20+14,50014,500 total
    Exercise: $6.93Exp: 2034-06-20Common Stock (14,500 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    75,000
  • Common Stock

    (indirect: By Trust)
    75,000
  • Common Stock

    (indirect: By Velocity Capital Management)
    139,672
Footnotes (5)
  • [F1]These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in full upon the earlier to occur of (a) June 20, 2025 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date.
  • [F2]The shares are held by the NEJ09 IRREVOCABLE TRUST dated December 24, 2020, of which the Reporting Person is a trustee.
  • [F3]The shares are held by the NEJ12 IRREVOCABLE TRUST dated December 24, 2020, of which the Reporting Person is a trustee.
  • [F4]Velosity Capital Management LLC is an entity that the Reporting Person is the sole member of.
  • [F5]This stock option will vest and become exercisable in full upon the earlier to occur of (a) June 20, 2025 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date.

Documents

1 file

Issuer

Aura Biosciences, Inc.

CIK 0001501796

Entity typeother

Related Parties

1
  • filerCIK 0001808098

Filing Metadata

Form type
4
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 4:05 PM ET
Size
9.9 KB